Kazmin D

No ORCID on file · 2 papers in corpus
2010
Molecular Endocrinology ·doi:10.1210/me.2010-0289

Both pro- and antimitogenic activities have been ascribed to progesterone receptor (PR) agonists and antagonists in breast cancer cells; however, the transcriptional responses that underlie these paradoxical functions are not apparent. Usin…

2010
Molecular Endocrinology ·doi:10.1210/me.2009-0339

Selective estrogen receptor modulators (SERMs), such as tamoxifen (TAM), have been used extensively for the treatment and prevention of breast cancer and other pathologies associated with aberrant estrogen receptor (ER) signaling. These com…